ArticleHepatobiliary surgery and nutrition2026

Dual TIGIT and PD-1 blockade in immunotherapy-refractory hepatocellular carcinoma: a signal beyond resistance?

Maria Stella Franzè et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.